A. Attinger

发表

The Caspase 8 Inhibitor c-FLIPL Modulates T-Cell Receptor-Induced Proliferation but Not Activation-Induced Cell Death of Lymphocytes

J. Tschopp, M. Hahne, S. Lens, 2002, Molecular and Cellular Biology.

Fas triggers an alternative, caspase-8–independent cell death pathway using the kinase RIP as effector molecule

Brian Seed, Margot Thome, Pascal Schneider, 2000, Nature Immunology.

CD8alphaalpha-mediated survival and differentiation of CD8 memory T cell precursors.

D. Littman, W. Ellmeier, M. Sundarrajan, 2004, Science.

Expression of B220 on activated T cell blasts precedes apoptosis.

J. Tschopp, M. Hahne, H. Macdonald, 1997, European journal of immunology.

The NAD biosynthesis inhibitor APO866 has potent antitumor activity against hematologic malignancies.

P. Greaney, C. Ireson, J. Tjørnelund, 2009, Blood.

Cutting edge: apoptosis of superantigen-activated T cells occurs preferentially after a discrete number of cell divisions in vivo.

H. Macdonald, T. Renno, A. Attinger, 1999, Journal of immunology.

A novel potent Fas agonist for selective depletion of tumor cells in hematopoietic transplants

S. Demotz, P. Greaney, M. Schapira, 2011, Blood cancer journal.

Mycobacterium tuberculosis Intracellular Reduces the Viability of Fas Ligand-Induced Apoptosis of Infected Human

P. Meylan, M. Oddo, T. Renno, 2017 .

Transcriptional Reprogramming of Mature CD4+ T helper Cells generates distinct MHC class II-restricted Cytotoxic T Lymphocytes

K. Honda, W. Ellmeier, Gisen Kim, 2013, Nature Immunology.

Identification of Pre- and Postselection TCRαβ+ Intraepithelial Lymphocyte Precursors in the Thymus

B. Sullivan, H. Cheroutre, A. Attinger, 2006 .

Molecular Basis for the High Affinity Interaction between the Thymic Leukemia Antigen and the CD8αα Molecule1

E. Reinherz, L. Devine, P. Kavathas, 2005, The Journal of Immunology.

Peptide-Independent Folding and CD8αα Binding by the Nonclassical Class I Molecule, Thymic Leukemia Antigen1

E. Reinherz, M. Kronenberg, Y. Xiong, 2002, The Journal of Immunology.

Identification of pre- and postselection TCRalphabeta+ intraepithelial lymphocyte precursors in the thymus.

B. Sullivan, H. Cheroutre, A. Attinger, 2006, Immunity.

Lymphoid environment limits superantigen and antigen‐induced T cell proliferation at high precursor frequency

H. Macdonald, A. Attinger, H. Acha-Orbea, 2001, European journal of immunology.

Debio 0617B Inhibits Growth of STAT3-Driven Solid Tumors through Combined Inhibition of JAK, SRC, and Class III/V Receptor Tyrosine Kinases

P. Traxler, M. Lang, M. Ramachandra, 2016, Molecular Cancer Therapeutics.

against hematologic malignancies The NAD biosynthesis inhibitor APO866 has potent antitumor activity

P. Greaney, C. Ireson, M. Duchosal, 2011 .

Cell Divisions In Vivo Preferentially After a Discrete Number of Superantigen-Activated T Cells Occurs Cutting Edge : Apoptosis of

H. Macdonald, Bakker, T. Renno, 1999 .

Pairing of Vβ6 with certain Vα2 family members prevents T cell deletion by Mtv-7 superantigen

H. Macdonald, P. Marche, E. Jouvin-Marche, 2000 .

A Fas agonist induces high levels of apoptosis in haematological malignancies.

Isabelle Bassi, S. Demotz, P. Greaney, 2006, Leukemia research.

T cell responses modulated through interaction between CD8alphaalpha and the nonclassical MHC class I molecule, TL.

E. Reinherz, F. Koning, M. Kronenberg, 2001, Science.

T Cell Responses Modulated Through Interaction Between CD8αα and the Nonclassical MHC Class I Molecule, TL

Frits Koning, Hilde Cheroutre, Mitchell Kronenberg, 2001, Science.

Peptide-independent folding and CD8 alpha alpha binding by the nonclassical class I molecule, thymic leukemia antigen.

E. Reinherz, M. Kronenberg, Y. Xiong, 2002, Journal of immunology.

Effects of mycophenolic acid on human immunodeficiency virus infection in vitro and in vivo

G. Pantaleo, S. Fleury, Giuseppe Pantaleo, 2000, Nature Medicine.

Interplays between mouse mammary tumor virus and the cellular and humoral immune response

K. Toellner, I. Maclennan, L. Scarpellino, 1999, Immunological reviews.

An amyloid-forming segment of beta2-microglobulin suggests a molecular model for the fibril.

David Eisenberg, Michael R Sawaya, D. Eisenberg, 2004, Proceedings of the National Academy of Sciences of the United States of America.

CD8αα-Mediated Survival and Differentiation of CD8 Memory T Cell Precursors

Peter Jensen, Hilde Cheroutre, Dan R. Littman, 2004, Science.

Molecular basis for the high affinity interaction between the thymic leukemia antigen and the CD8alphaalpha molecule.

E. Reinherz, L. Devine, P. Kavathas, 2005, Journal of immunology.

Cutting Edge: Cell Autonomous Rather Than Environmental Factors Control Bacterial Superantigen-Induced T Cell Anergy In Vivo1

H. Macdonald, A. Attinger, H. Acha-Orbea, 2000, The Journal of Immunology.

Expression of B220 on activated T cell blasts precedes apoptosis

J. Tschopp, M. Hahne, H. Macdonald, 1998 .

The Multi-kinase Inhibitor Debio 0617B Reduces Maintenance and Self-renewal of Primary Human AML CD34+ Stem/Progenitor Cells

M. Ramachandra, M. Aguet, Y. Banz, 2017, Molecular Cancer Therapeutics.

Fas ligand-induced apoptosis of infected human macrophages reduces the viability of intracellular Mycobacterium tuberculosis.

H. Macdonald, P. Meylan, M. Oddo, 1998, Journal of immunology.

SAFETY AND EFFICACY OF CD37‐TARGETING NARATUXIMAB EMTANSINE PLUS RITUXIMAB IN DIFFUSE LARGE B‐CELL LYMPHOMA AND OTHER NON‐HODGKIN’S B‐CELL LYMPHOMAS – A PHASE 2 STUDY

H. Nauwelaerts, M. André, M. Trněný, 2021, Hematological Oncology.

The Multi-kinase Inhibitor Debio 0617B Reduces Maintenance and Self-renewal of Primary Human AML CD34+ Stem/Progenitor Cells

M. Ramachandra, M. Aguet, Y. Banz, 2017, Molecular Cancer Therapeutics.

The NAD biosynthesis inhibitor APO866 has potent antitumor activity against hematologic malignancies.

P. Greaney, C. Ireson, J. Tjørnelund, 2009, Blood.